Suppr超能文献

血管内皮生长因子受体的二聚化及其对信号转导的影响:一项计算研究。

Dimerization of VEGF receptors and implications for signal transduction: a computational study.

作者信息

Mac Gabhann Feilim, Popel Aleksander S

机构信息

Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

Biophys Chem. 2007 Jul;128(2-3):125-39. doi: 10.1016/j.bpc.2007.03.010. Epub 2007 Mar 24.

Abstract

Vascular endothelial growth factor (VEGF) is a potent cytokine involved in the induction of neovascularization. Secreted as a cysteine-linked dimer, it has two binding sites at opposite poles through which it may bind VEGF receptors (VEGFRs), receptor tyrosine kinases found on the surface of endothelial and other cells. The binding of a VEGF molecule to two VEGFR molecules induces transphosphorylation of the intracellular domains of the receptors, leading to signal transduction. The dominant mechanism of receptor dimerization is not clear: the receptors may be present in an inactive pre-dimerized form, VEGF binding first to one of the receptors, the second receptor then ideally located for dimerization; or VEGF may bind receptor monomers on the cell surface, which then diffuse and bind to available unligated receptor monomers to complete the activation. Both processes take place and one or other may dominate on different cell types. We demonstrate the impact of dimerization mechanism on the binding of VEGF to the cell surface and on the formation of active signaling receptor complexes. We describe two methods to determine which process dominates, based on binding and phosphorylation assays. The presence of two VEGF receptor populations, VEGFR1 and VEGFR2, can result in receptor heterodimer formation. Our simulations predict that heterodimers will comprise 10-50% of the active, signaling VEGF receptor complexes, and that heterodimers will form at the expense of homodimers of VEGFR1 when VEGFR2 populations are larger. These results have significant implications for VEGF signal transduction and interpretation of experimental studies. These results may be applicable to other ligand-receptor pairs, in particular PDGF.

摘要

血管内皮生长因子(VEGF)是一种参与诱导新血管形成的强效细胞因子。它以半胱氨酸连接的二聚体形式分泌,在相对的两极有两个结合位点,通过这些位点它可以结合VEGF受体(VEGFRs),VEGFRs是在内皮细胞和其他细胞表面发现的受体酪氨酸激酶。一个VEGF分子与两个VEGFR分子的结合会诱导受体胞内结构域的反式磷酸化,从而导致信号转导。受体二聚化的主要机制尚不清楚:受体可能以无活性的预二聚体形式存在,VEGF首先与其中一个受体结合,然后第二个受体处于理想的二聚化位置;或者VEGF可能与细胞表面的受体单体结合,然后这些单体扩散并与可用的未结合配体的受体单体结合以完成激活。这两个过程都会发生,并且在不同的细胞类型中可能其中一个占主导。我们证明了二聚化机制对VEGF与细胞表面结合以及活性信号受体复合物形成的影响。我们描述了两种基于结合和磷酸化测定来确定哪个过程占主导的方法。两种VEGF受体群体VEGFR1和VEGFR2的存在会导致受体异二聚体的形成。我们的模拟预测,异二聚体将占活性信号VEGF受体复合物的10 - 50%,并且当VEGFR2群体较大时,异二聚体将以牺牲VEGFR1的同二聚体为代价形成。这些结果对VEGF信号转导和实验研究的解释具有重要意义。这些结果可能适用于其他配体 - 受体对,特别是血小板衍生生长因子(PDGF)。

相似文献

1
Dimerization of VEGF receptors and implications for signal transduction: a computational study.
Biophys Chem. 2007 Jul;128(2-3):125-39. doi: 10.1016/j.bpc.2007.03.010. Epub 2007 Mar 24.
2
Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2425-30. doi: 10.1073/pnas.0914318107.
5
VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.
PLoS One. 2022 Jul 21;17(7):e0269818. doi: 10.1371/journal.pone.0269818. eCollection 2022.
6
Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
J Biol Chem. 2015 Jun 26;290(26):16451-62. doi: 10.1074/jbc.M114.627372. Epub 2015 May 15.
7
Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity.
Vascul Pharmacol. 2017 Jan;88:11-20. doi: 10.1016/j.vph.2016.11.007. Epub 2016 Nov 22.
8
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Cell Death Differ. 2010 Mar;17(3):499-512. doi: 10.1038/cdd.2009.152. Epub 2009 Oct 16.
9
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H153-64. doi: 10.1152/ajpheart.00254.2003. Epub 2003 Apr 24.
10
Monte Carlo simulations of VEGF binding to cell surface receptors in vitro.
Biochim Biophys Acta. 2005 Dec 15;1746(2):95-107. doi: 10.1016/j.bbamcr.2005.09.004. Epub 2005 Oct 5.

引用本文的文献

1
Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells.
PLoS Comput Biol. 2025 Jul 16;21(7):e1013254. doi: 10.1371/journal.pcbi.1013254. eCollection 2025 Jul.
2
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
3
Multiscale computational model predicts how environmental changes and treatments affect microvascular remodeling in fibrotic disease.
PNAS Nexus. 2024 Dec 7;4(1):pgae551. doi: 10.1093/pnasnexus/pgae551. eCollection 2025 Jan.
4
The metastatic cascade through the lens of therapeutic inhibition.
Cell Rep Med. 2025 Jan 21;6(1):101872. doi: 10.1016/j.xcrm.2024.101872. Epub 2024 Dec 19.
5
Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression.
NPJ Syst Biol Appl. 2024 Oct 22;10(1):122. doi: 10.1038/s41540-024-00453-2.
8
Effects of the Foam Massage Roller on VEGF-A and FGF-2 Blood Levels in Young Men.
In Vivo. 2023 Sep-Oct;37(5):2057-2069. doi: 10.21873/invivo.13303.
9
Complement factor H inhibits endothelial cell migration through suppression of STAT3 signaling.
Exp Ther Med. 2023 Jul 10;26(2):408. doi: 10.3892/etm.2023.12107. eCollection 2023 Aug.

本文引用的文献

1
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy.
PLoS Comput Biol. 2006 Sep 22;2(9):e127. doi: 10.1371/journal.pcbi.0020127. Epub 2006 Aug 3.
2
VEGF receptor signalling - in control of vascular function.
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71. doi: 10.1038/nrm1911.
3
Biology of vascular endothelial growth factors.
FEBS Lett. 2006 May 22;580(12):2879-87. doi: 10.1016/j.febslet.2006.03.087. Epub 2006 Apr 17.
4
Spatial modeling of dimerization reaction dynamics in the plasma membrane: Monte Carlo vs. continuum differential equations.
Biophys Chem. 2006 Jun 1;121(3):194-208. doi: 10.1016/j.bpc.2006.01.008. Epub 2006 Feb 28.
5
Angiogenesis in rheumatoid arthritis.
Histol Histopathol. 2006 May;21(5):557-66. doi: 10.14670/HH-21.557.
6
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Exp Cell Res. 2006 Mar 10;312(5):594-607. doi: 10.1016/j.yexcr.2005.11.015. Epub 2005 Dec 22.
7
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.
Exp Cell Res. 2006 Mar 10;312(5):549-60. doi: 10.1016/j.yexcr.2005.11.012. Epub 2005 Dec 5.
8
Computational modeling reveals molecular details of epidermal growth factor binding.
BMC Cell Biol. 2005 Nov 30;6:41. doi: 10.1186/1471-2121-6-41.
9
Monte Carlo simulations of VEGF binding to cell surface receptors in vitro.
Biochim Biophys Acta. 2005 Dec 15;1746(2):95-107. doi: 10.1016/j.bbamcr.2005.09.004. Epub 2005 Oct 5.
10
A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity.
Biosystems. 2006 Feb-Mar;83(2-3):136-51. doi: 10.1016/j.biosystems.2005.06.014. Epub 2005 Oct 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验